In our new Industry Voice video podcast episode, join OCT Clinical in discussing the future of chronic metabolic diseases alongside QL Biopharm, a pioneering drug manufacturing company from China. Discover the cutting-edge insights and innovative strategies that QL Biopharm brings to the table, aiming to transform the landscape of chronic metabolic diseases and pharma market in China and around the globe.
